Skip to content

Insider · CIK 0001962926

Xichen Lin

officer

Files at GPCR (Structure Therapeutics Inc.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 1, 2026GPCR
Structure Therapeutics Inc.
MOption exercise
Ordinary Shares10b5-1
+17,817$0.34$6,058246,77740 d ago
Sep 1, 2026GPCR
Structure Therapeutics Inc.
CConversion
Ordinary Shares10b5-1
-17,817$0.00$0228,96040 d ago
Sep 1, 2026GPCR
Structure Therapeutics Inc.
MOption exercise
Share Option (right to buy)derivative10b5-1
-17,817$0.00$0125,08140 d ago
Sep 1, 2026GPCR
Structure Therapeutics Inc.
CConversion
American Depositary Sharesderivative10b5-1
+5,939$0.00$05,93940 d ago
Sep 1, 2026GPCR
Structure Therapeutics Inc.
SOpen-market sale
American Depositary Sharesderivative10b5-1
-1,300$45.86$60k4,63940 d ago
Sep 1, 2026GPCR
Structure Therapeutics Inc.
SOpen-market sale
American Depositary Sharesderivative10b5-1
-4,539$47.20$214k10040 d ago
Sep 1, 2026GPCR
Structure Therapeutics Inc.
SOpen-market sale
American Depositary Sharesderivative10b5-1
-100$47.83$4,783040 d ago
Mar 19, 2026GPCR
Structure Therapeutics Inc.
AGrant or award
Ordinary Shares
+43,368$0.00$0228,960Mar 23, 2026
Mar 19, 2026GPCR
Structure Therapeutics Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+53,703$0.00$053,703Mar 23, 2026
Mar 3, 2026GPCR
Structure Therapeutics Inc.
FTax withholding
Ordinary Shares
-18,735$20.99$393k185,592Mar 5, 2026
Jul 1, 2025GPCR
Structure Therapeutics Inc.
FTax withholding
Ordinary Shares
-12,846$6.84$88k204,327Aug 20, 2025
Mar 1, 2025GPCR
Structure Therapeutics Inc.
FTax withholding
Ordinary Shares
-6,441$7.92$51k160,095Jul 3, 2025
Jul 1, 2025GPCR
Structure Therapeutics Inc.
AGrant or award
Ordinary Shares
+57,078$0.00$0217,173Jul 3, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Xichen Lin: insider trades and track record | InsiderTell